{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:45:03Z","timestamp":1791431103213,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polypharmacy is a growing public health concern, yet its association with area-level socioeconomic deprivation in England has been under-explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate whether socioeconomic\u00a0deprivation, measured by the Index of Multiple Deprivation (IMD), is associated with polypharmacy among adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We analysed cross-sectional data from the 2021 Health Survey for England, including 1705 adults aged 16+\u2009who completed nurse visits and reported prescribed medication use in the past week. Polypharmacy was defined as the use of five or more prescribed medications. IMD scores were categorised into quintiles (least to most deprived). Multivariable logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs), controlling for age, sex, ethnicity, multimorbidity, obesity, smoking, alcohol use, and GP visit frequency. A polynomial contrast test assessed linear trends, and adjusted predicted probabilities were calculated to illustrate the deprivation\u2013polypharmacy gradient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the fully adjusted model, adults residing in the most deprived IMD quintile had significantly higher odds of polypharmacy (OR 1.82; 95% CI 1.09\u20133.04;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022) compared to those living in the least deprived areas. No statistically significant associations were observed for intermediate quintiles. A polynomial contrast test confirmed a significant linear trend across IMD levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010), indicating that the odds of polypharmacy increased progressively with greater area-level deprivation. This gradient was further illustrated by adjusted predicted probabilities, which rose from 18.3% (95% CI 15.3\u201321.3%) in the least deprived quintile to 24.6% (95% CI 20.1\u201329.2%) in the most deprived (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Socioeconomic deprivation is independently associated with polypharmacy, even after adjusting for multimorbidity and other confounders, highlighting persistent health inequalities within England\u2019s healthcare system. Targeted strategies, including regular medication reviews and enhanced access to care in deprived communities, may help mitigate risks and promote equity in prescribing practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-025-01990-4","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:50:43Z","timestamp":1755935443000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Socioeconomic deprivation and its association with polypharmacy in England: results from a national cross-sectional survey"],"prefix":"10.1007","volume":"48","author":[{"given":"Yusuff Adebayo","family":"Adebisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najim Z.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa Abdullah","family":"Bafail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"issue":"3","key":"1990_CR1","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11096-025-01882-7","volume":"47","author":"GB Lee","year":"2025","unstructured":"Lee GB, Hosking SM, Etherton-Beer C, et al. Defining polypharmacy in older adults: a cross-sectional comparison of prevalence estimates calculated according to active ingredient and unique product counts. Int J Clin Pharm. 2025;47(3):824\u201333.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"1990_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016358","volume":"7","author":"NN Dhalwani","year":"2017","unstructured":"Dhalwani NN, Fahami R, Sathanapally H, et al. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017;7(10): e016358. https:\/\/doi.org\/10.1136\/bmjopen-2017-016358.","journal-title":"BMJ Open"},{"issue":"1","key":"1990_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12877-023-03835-z","volume":"23","author":"A Iqbal","year":"2023","unstructured":"Iqbal A, Richardson C, Iqbal Z, et al. Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis. BMC Geriatr. 2023;23(1):149.","journal-title":"BMC Geriatr"},{"issue":"Suppl 1","key":"1990_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/geroni\/igad104.1795","volume":"7","author":"A Iqbal","year":"2023","unstructured":"Iqbal A, Hanratty B, Matthews F, et al. Inequalities in polypharmacy in adults aged 65+ in England. Innov Aging. 2023;7(Suppl 1):546\u20137.","journal-title":"Innov Aging"},{"issue":"1","key":"1990_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12877-018-0795-2","volume":"18","author":"MJ Rawle","year":"2018","unstructured":"Rawle MJ, Richards M, Davis D, et al. The prevalence and determinants of polypharmacy at age 69: a British birth cohort study. BMC Geriatr. 2018;18(1):118.","journal-title":"BMC Geriatr"},{"issue":"3","key":"1990_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s11096-024-01859-y","volume":"47","author":"L Clarkson","year":"2025","unstructured":"Clarkson L, Griffiths A, Ng SK, et al. Preadmission medications and recent falls in older inpatients: an observational study. Int J Clin Pharm. 2025;47(3):708\u201316.","journal-title":"Int J Clin Pharm"},{"key":"1990_CR7","unstructured":"Department of Health and Social Care. Good for you, good for us, good for everybody: a plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions. https:\/\/assets.publishing.service.gov.uk\/media\/614a10fed3bf7f05ab786551\/good-for-you-good-for-us-good-for-everybody.pdf Accessed on 15 July 2025"},{"key":"1990_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.116961","volume":"351","author":"M Mart\u00ednez-Jim\u00e9nez","year":"2024","unstructured":"Mart\u00ednez-Jim\u00e9nez M, Hollingsworth B, Zucchelli E. Socioeconomic deprivation, health and healthcare utilisation among millennials. Soc Sci Med. 2024;351:116961.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1990_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12061-022-09486-8","volume":"16","author":"CD Lloyd","year":"2023","unstructured":"Lloyd CD, Norman PD, McLennan D. Deprivation in England, 1971\u20132020. Appl Spat Anal Policy. 2023;16(1):461\u201384.","journal-title":"Appl Spat Anal Policy"},{"key":"1990_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2147\/COPD.S157594","volume":"13","author":"PF Collins","year":"2018","unstructured":"Collins PF, Stratton RJ, Kurukulaaratchy RJ, et al. Influence of deprivation on health care use, health care costs, and mortality in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1289\u201396.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"1990_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1302\/2633-1462.310.BJO-2022-0037.R1","volume":"3","author":"K Kulkarni","year":"2022","unstructured":"Kulkarni K, Shah R, Mangwani J, et al. The impact of deprivation on patients awaiting planned care. Bone Jt Open. 2022;3(10):777\u201385.","journal-title":"Bone Jt Open"},{"issue":"1","key":"1990_CR12","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/s41598-022-11310-9","volume":"12","author":"G Knies","year":"2022","unstructured":"Knies G, Kumari M. Multimorbidity is associated with the income, education, employment and health domains of area-level deprivation in adult residents in the UK. Sci Rep. 2022;12(1):7280.","journal-title":"Sci Rep"},{"key":"1990_CR13","unstructured":"Health Survey for England 2021 Methods. https:\/\/files.digital.nhs.uk\/58\/751EC9\/Health%20Survey%20for%20England%2C%202021%20Methods%20v2.pdf Accessed on 16 April 2025"},{"key":"1990_CR14","unstructured":"The English Indices of Deprivation 2019. https:\/\/assets.publishing.service.gov.uk\/media\/5d8b387740f0b609909b5908\/IoD2019_Technical_Report.pdf Accessed on 16 April 2025"},{"issue":"1","key":"1990_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/pubmed\/fdh210","volume":"27","author":"J Adams","year":"2005","unstructured":"Adams J, White M. Socio-economic deprivation is associated with increased proximity to general practices in England: an ecological analysis. J Public Health (Oxf). 2005;27(1):80\u20131.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"1990_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020270","volume":"8","author":"N Slater","year":"2018","unstructured":"Slater N, White S, Venables R, et al. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA). BMJ Open. 2018;8(3):e020270.","journal-title":"BMJ Open"},{"issue":"1","key":"1990_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12877-022-03536-z","volume":"22","author":"L Ye","year":"2022","unstructured":"Ye L, Yang-Huang J, Franse CB, et al. Factors associated with polypharmacy and the high risk of medication-related problems among older community-dwelling adults in European countries: a longitudinal study. BMC Geriatr. 2022;22(1):841.","journal-title":"BMC Geriatr"},{"issue":"5","key":"1990_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054584","volume":"12","author":"J Downing","year":"2022","unstructured":"Downing J, Taylor R, Mountain R, et al. Socioeconomic and health factors related to polypharmacy and medication management: analysis of a household health survey in North West Coast England. BMJ Open. 2022;12(5): e054584.","journal-title":"BMJ Open"},{"issue":"5","key":"1990_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00228-013-1639-9","volume":"70","author":"RA Payne","year":"2014","unstructured":"Payne RA, Avery AJ, Duerden M, et al. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70(5):575\u201381.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"1990_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063137","volume":"12","author":"I Holdroyd","year":"2022","unstructured":"Holdroyd I, Vodden A, Srinivasan A, et al. Systematic review of the effectiveness of the health inequalities strategy in England between 1999 and 2010. BMJ Open. 2022;12(9): e063137.","journal-title":"BMJ Open"},{"issue":"1","key":"1990_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1186\/s12913-023-10030-8","volume":"23","author":"HJ Lowther-Payne","year":"2023","unstructured":"Lowther-Payne HJ, Ushakova A, Beckwith A, et al. Understanding inequalities in access to adult mental health services in the UK: a systematic mapping review. BMC Health Serv Res. 2023;23(1):1042.","journal-title":"BMC Health Serv Res"},{"issue":"10288","key":"1990_CR22","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(21)00229-4","volume":"397","author":"M McKee","year":"2021","unstructured":"McKee M, Dunnell K, Anderson M, et al. The changing health needs of the UK population. Lancet. 2021;397(10288):1979\u201391.","journal-title":"Lancet"},{"issue":"2\u20133","key":"1990_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.healthpol.2011.07.002","volume":"103","author":"J Costa Font","year":"2011","unstructured":"Costa Font J, Hern\u00e1ndez-Quevedo C, McGuire A. Persistence despite action? Measuring the patterns of health inequality in England (1997\u20132007). Health Policy. 2011;103(2\u20133):149\u201359.","journal-title":"Health Policy"},{"issue":"7","key":"1990_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20075237","volume":"20","author":"K Bernard","year":"2023","unstructured":"Bernard K, Wildman JM, Tanner LM, et al. Experiences of non-pharmaceutical primary care interventions for common mental health disorders in socioeconomically disadvantaged groups: a systematic review of qualitative studies. Int J Environ Res Public Health. 2023;20(7): 5237.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"1990_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1472-6963-7-71","volume":"17","author":"C Hutton","year":"2007","unstructured":"Hutton C, Gunn J. Do longer consultations improve the management of psychological problems in general practice? A systematic literature review. BMC Health Serv Res. 2007;17(7):71.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"1990_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.sapharm.2015.12.001","volume":"12","author":"H Wali","year":"2016","unstructured":"Wali H, Hudani Z, Wali S, et al. A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm. 2016;12(6):830\u201364.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"1990_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s11096-024-01735-9","volume":"46","author":"L Van der Linden","year":"2024","unstructured":"Van der Linden L, Tournoy J. Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012\u20132021). Int J Clin Pharm. 2024;46(4):987\u201391.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1990_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11096-024-01809-8","volume":"47","author":"S Su","year":"2025","unstructured":"Su S, Zhu X, Wu S, et al. Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study. Int J Clin Pharm. 2025;47(1):80\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1990_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11096-024-01840-9","volume":"47","author":"M Stuhec","year":"2025","unstructured":"Stuhec M. Medication reconciliation and seamless care led by clinical pharmacists in Slovenia: a national reimbursed program ensuring safe and effective transition of care. Int J Clin Pharm. 2025;47(2):239\u201346. https:\/\/doi.org\/10.1007\/s11096-024-01840-9.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"1990_CR30","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s11096-023-01643-4","volume":"45","author":"M Stuhec","year":"2023","unstructured":"Stuhec M, Hahn M, Taskova I, et al. Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health. Int J Clin Pharm. 2023;45(5):1286\u201392. https:\/\/doi.org\/10.1007\/s11096-023-01643-4.","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01990-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01990-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01990-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:18:49Z","timestamp":1768972729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01990-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01990-4","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a secondary analysis of Health Survey for England (HSE) 2021 data, so ethical approval was not sought. The original HSE 2021 study received approval from the East Midlands Nottingham 2 Research Ethics Committee (Reference no. 15\/EM\/0254), ensuring the protection of participants\u2019 rights, safety, and wellbeing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}